Moleculin Biotech is trading 5.4% up at $0.87 as broader markets rally following August inflation data.
- No clear company-specific catalyst directly explains the move.
- Moleculin’s H.C. Wainwright conference presentation became available at 7:00 a.m. ET on September 11, 2026, but the release did not link it to trading activity.
- Major indexes are also up more than 0.5%, supporting a global risk-on explanation.